Practical issues in data monitoring of clinical trials: Summary of responses to a questionnaire at nih.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 543, doi. 10.1002/sim.4780120520
- By:
- Publication type:
- Article
Works matching IS 02776715 AND DT 1993 AND VI 12 AND IP 5/6
Results: 31
1
2
Closing remarks.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 615, doi. 10.1002/sim.4780120531
- Publication type:
- Article
3
Preface.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 415, doi. 10.1002/sim.4780120502
- By:
- Publication type:
- Article
4
Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 481, doi. 10.1002/sim.4780120513
- By:
- Publication type:
- Article
5
Data monitoring committees and capturing relevant information of high quality.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 565, doi. 10.1002/sim.4780120524
- By:
- Publication type:
- Article
6
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 433, doi. 10.1002/sim.4780120506
- Publication type:
- Article
7
Interim analyses, stopping rules and data monitoring in clinical trials in europe.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 509, doi. 10.1002/sim.4780120517
- By:
- Publication type:
- Article
8
Panel discussion: Scientific issues in data monitoring.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 583, doi. 10.1002/sim.4780120528
- Publication type:
- Article
9
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 609, doi. 10.1002/sim.4780120530
- Publication type:
- Article
10
Masthead.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. fmi, doi. 10.1002/sim.4780120501
- Publication type:
- Article
11
Data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 471, doi. 10.1002/sim.4780120512
- By:
- Publication type:
- Article
12
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 563, doi. 10.1002/sim.4780120523
- Publication type:
- Article
13
The NHLBI model: A 25 year history.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 425, doi. 10.1002/sim.4780120505
- By:
- Publication type:
- Article
14
The use of data monitoring committees in canadian trial groups.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 505, doi. 10.1002/sim.4780120516
- By:
- Publication type:
- Article
15
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 581, doi. 10.1002/sim.4780120527
- Publication type:
- Article
16
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 457, doi. 10.1002/sim.4780120509
- Publication type:
- Article
17
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 469, doi. 10.1002/sim.4780120511
- Publication type:
- Article
18
Data monitoring boards in the pharmaceutical industry.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 555, doi. 10.1002/sim.4780120522
- By:
- Publication type:
- Article
19
Behind closed doors: The data monitoring board in randomized clinical trials.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 419, doi. 10.1002/sim.4780120504
- By:
- Publication type:
- Article
20
Monitoring clinical trials: Experience of, and proposals under consideration by, the cancer therapy committee of the British medical research council.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 497, doi. 10.1002/sim.4780120515
- By:
- Publication type:
- Article
21
Data monitoring committees: The moral case for maximum feasible independence.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 575, doi. 10.1002/sim.4780120526
- By:
- Publication type:
- Article
22
Data monitoring committees for southwest oncology group clinical trials.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 451, doi. 10.1002/sim.4780120508
- By:
- Publication type:
- Article
23
Panel discussion: The operation of data monitoring committees.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 527, doi. 10.1002/sim.4780120519
- Publication type:
- Article
24
The use of external monitoring committees in clinical trials of the national institute of allergy and infectious diseases.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 461, doi. 10.1002/sim.4780120510
- By:
- Publication type:
- Article
25
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 553, doi. 10.1002/sim.4780120521
- Publication type:
- Article
26
Opening Remarks.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 417, doi. 10.1002/sim.4780120503
- Publication type:
- Article
27
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 493, doi. 10.1002/sim.4780120514
- Publication type:
- Article
28
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 571, doi. 10.1002/sim.4780120525
- Publication type:
- Article
29
A survey of monitoring practices in cancer clinical trials.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 435, doi. 10.1002/sim.4780120507
- By:
- Publication type:
- Article
30
Discussion.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 521, doi. 10.1002/sim.4780120518
- Publication type:
- Article
31
Some FDA perspectives on data monitoring in clinical trials in drug development.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 601, doi. 10.1002/sim.4780120529
- By:
- Publication type:
- Article